EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro liposome release profile prediction using explainable machine learning approaches

Hamza Abu Owida iD, Sameer Ahmad Hasan iD, Areen Arabiat iD, Suhaila Abuowaida

PLOS One · 11.08.2026 · 21 (8) · e0354293

DOI: 10.1371/journal.pone.0354293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 11.08.2026. Verfasst von Hamza Abu Owida und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Engineering, Faculty of Engineering, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Liposomes, Machine Learning, Drug Liberation. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Formulation features and test settings influence liposomal in vitro release (IVR) profiles, yet it is challenging to examine these multivariable associations across varied literature data. We created an explainable computational workflow in this proof-of-concept study for classifying liposomal release phenotypes and identify formulation/assay features linked to slow and fast release. Benchmarking kinetic models, simulating Weibull-parameterized release curves on a shared 0–168 h grid, clustering profiles using PCA and k-means, and training supervised classifiers on formulation and IVR descriptors were all done using a publicly available Accelerated IVR dataset. Slow, moderate, and fast kinetic phenotypes were found using PCA-k-means; 98.4% of the variance was explained by the first two principal components. XGBoost demonstrated the best cross-validated performance across evaluated models for the extreme slow-versus-fast subgroup (n = 59); however, class-wise recall and precision indicate preliminary rather than conclusive prediction performance. The most informative descriptors identified by feature selection and SHAP interpretation were media pH, drug loading, weighted lipid transition temperature, and media temperature. These results indicated that risk-based IVR technique development and hypothesis creation for liposomal formulations can be supported by explainable ML; nevertheless, prior to translational or regulatory usage, prospective validation on independently generated datasets is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesMachine LearningDrug LiberationBoosting Machine Learning AlgorithmsKineticsPrincipal Component AnalysisPredictive Learning ModelsPrediction AlgorithmsClassification AlgorithmsClustering Algorithms

Substanzen

Liposomes

Autor:innen und Institutionen

  • Department of Medical Engineering, Faculty of Engineering, Al-Ahliyya Amman University, Amman, Jordan.
  • Department of Biomedical Engineering, School of Applied Medical Sciences, German Jordanian University, Amman, Jordan.
  • Department of Communications and Computer Engineering, Faculty of Engineering, Al-Ahliyya Amman University, Amman, Jordan.
  • Department of Data Science and Artificial Intelligence, Faculty of Prince Al-Hussein Bin Abdallah II for Information Technology, Al Al-Bayt University, Mafraq, Jordan.

ORCID-Profile: Hamza Abu Owida, Sameer Ahmad Hasan, Areen Arabiat

Zitieren

APA

Owida, H. A., Ahmad Hasan, S., Arabiat, A., & Abuowaida, S. (2026). In Vitro liposome release profile prediction using explainable machine learning approaches. PLOS One, 21(8), e0354293. https://doi.org/10.1371/journal.pone.0354293

Vancouver

Owida HA, Ahmad Hasan S, Arabiat A, Abuowaida S. In Vitro liposome release profile prediction using explainable machine learning approaches. PLOS One. 2026;21(8):e0354293. doi:10.1371/journal.pone.0354293

BibTeX
@article{Owida2026,
  author = {Owida, Hamza Abu and Ahmad Hasan, Sameer and Arabiat, Areen and Abuowaida, Suhaila},
  title = {In Vitro liposome release profile prediction using explainable machine learning approaches},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0354293},
  doi = {10.1371/journal.pone.0354293}
}
Kostenlos starten →